David Vesely MD, PhD

Dr. David Lynn Vesely, MD, PhD, is working as a Professor at the University of South Florida College of Public Health. He received his Doctor of Medicine from the University of Arizona College of Medicine – Tucson. He discovered three cardiovascular hormones, i.e. vessel dilator, long-acting natriuretic peptide, and kaliuretic peptide, which constitute 97% of the circulating cardiac hormones in humans.

He demonstrated their biological effects and mechanism(s) of action, and that these peptide hormones have beneficial hemodynamic, natriuretic, and diuretic effects in humans with congestive heart failure (CHF). A vessel dilator, for example, enhances sodium excretion and water flow 5-fold in persons with CHF. Vessel dilator also ameliorates acute renal failure even when present for 2 days and regenerates the nuclei within the tubules within 6 days while normalizing serum creatinine levels.

Dr. Vesely has demonstrated that these cardiac hormones can eliminate up to 97% of human cancer cells (breast, pancreatic, ovarian, colon, prostate, glioblastomas of brain, small-cell and squamous cell lung cancers) in culture within 24 hours and when infused subcutaneously for 28 days eliminate up to 80% of human pancreatic cancers, two-thirds of human breast cancers growing in mice and up to 86% of human small-cell lung cancers in mice.

His research interests are Endocrinology, Diabetes, Metabolic Diseases, Internal Medicine, Molecular Pharmacology, and Physiology.